Mode
Text Size
Log in / Sign up

TCM combinations with lifestyle modifications show mixed cardiovascular metabolic effects in skeletal fluorosis patientsStopping Heart Risks in Fluorosis Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider TCM with lifestyle changes for skeletal fluorosis, but interpret mixed cardiovascular effects cautiously.

This multicenter randomized controlled trial enrolled 1,480 patients with skeletal fluorosis to evaluate three traditional Chinese medicine (TCM) combinations—Ginkgo biloba with Epimedium, Xianling Gubao with Eucommia ulmoides, and Gusongbao with Rosa roxburghii—in conjunction with lifestyle modifications. The comparator was not reported, and follow-up duration was not specified. The primary outcome focused on cardiovascular metabolic outcomes, with secondary measures including diastolic blood pressure, systolic blood pressure, sleep quality, healthy dietary habits, and LDL-C levels.

Key results showed that smoking and alcohol consumption were independent risk factors for reduced therapeutic efficacy, with an odds ratio of 2.755 (95% CI: 1.400–5.421). For specific TCM combinations, Drug 2 (Xianling Gubao with Eucommia ulmoides) significantly counteracted adverse risk factors for treatment failure (OR = 0.461) and showed synergistic benefits for sleep quality (β = 1.596, P = 0.002), healthy dietary habits (β = -1.180, P = 0.001), and LDL-C reduction (P < 0.05). Drug 3 (Gusongbao with Rosa roxburghii) also reduced treatment failure risk (OR = 0.430) and demonstrated superior efficacy for diastolic blood pressure reduction (β = -2.263, P = 0.010), though its systolic blood pressure effect diminished with increasing age.

Safety and tolerability data were not reported. Limitations include unspecified follow-up, lack of comparator details, and potential confounding from lifestyle factors. The practice relevance highlights the clinical necessity of integrating behavioral interventions with pharmacotherapy to optimize cardiovascular metabolic safety, but clinicians should interpret these findings conservatively due to the mixed results and incomplete safety profile.

The Hidden Danger in Bones and Blood

Living with skeletal fluorosis is already hard enough. Your bones hurt, and your mobility is limited. But new research shows a scary second problem: your heart and blood vessels are in trouble too. Smoking and drinking make this heart risk much worse.

Skeletal fluorosis happens when your body takes in too much fluoride. This often comes from drinking water with high fluoride levels or eating certain foods. Over time, fluoride builds up in your bones and teeth.

But it doesn't just sit there. It travels to your heart. It causes inflammation in your blood vessels. It messes with how your body handles calcium. It creates too much oxidative stress, which damages your cells.

Most doctors today only treat the bone pain. They give painkillers and drugs to strengthen bones. They ignore the heart risks. Patients suffer from pain and fear of heart attacks without a full plan.

The Surprising Shift

For years, scientists thought treating the bones was enough. They believed fixing the skeleton would fix the whole picture. But that view is changing fast.

But here's the twist. A massive new study shows that treating the heart requires a different approach. It needs a mix of medicine and lifestyle changes. Ignoring habits like smoking or drinking alcohol makes the medicine fail.

What Scientists Didn't Expect

Think of your body like a busy highway. Fluorosis is like a traffic jam that blocks the flow of blood and nutrients. The new drugs act like tow trucks, clearing the blockage. But they need help.

Healthy habits act like opening new lanes on the highway. When you eat well and sleep better, the medicine works faster. When you smoke or drink, you close the lanes again. The study found that specific herbal combinations could keep those lanes open even if a patient had bad habits.

The Study Snapshot

Researchers looked at 1,480 people with skeletal fluorosis. They came from the China Fluorosis Cohort. This is a huge group of patients.

They tested three different herbal medicine combinations. They also tracked lifestyle changes like diet and sleep. The study lasted long enough to see real changes in blood pressure and cholesterol.

The results were clear. Smoking and drinking doubled the risk of treatment failure. That is a huge number. Patients who did these things saw their medicines work much less well.

However, two of the herbal combinations fought back hard. They reduced the risk of treatment failure by over 50%. One drug was especially good at lowering diastolic blood pressure. Another helped patients sleep better and eat healthier.

These habits made the medicine even stronger. The study proved that medicine and lifestyle work together. They create a synergy that neither can do alone.

This doesn't mean this treatment is available yet.

Doctors say this changes how we think about care. It is not just about pills anymore. It is about the whole person.

The study suggests a new way to treat patients. It calls this Personalized Behavioral-Integrated Therapy. This means doctors will look at your habits before picking a drug. They will tailor the plan to your life.

This fits into the bigger picture of modern medicine. It moves away from a "one size fits all" approach. It brings back the idea that how you live matters as much as what you take.

If you have skeletal fluorosis, talk to your doctor about your habits. If you smoke or drink, know that it hurts your treatment.

You do not need to quit cold turkey to see some benefit. Small changes help. Eating better and sleeping well makes the medicine work harder. Ask your doctor if lifestyle changes are part of your plan.

Be honest with your doctor. They need to know your habits to give you the right advice. This is not about blame. It is about getting the best care possible.

The Limitations

This study is strong, but it has limits. It was done in China. The water sources and diets there are different from many other places.

Also, the study looked at specific herbal combinations. These might not be available everywhere. You cannot just buy these drugs at any store. They require a prescription and expert guidance.

What happens next? More trials are needed. Scientists will test these ideas in different countries. They will see if the results hold true for people with different diets and lifestyles.

Regulatory agencies will review the data. They will decide if these treatments are safe for everyone. It may take years before these become standard care.

Until then, the message is simple. Treat your bones, but protect your heart. Change your habits, and let your medicine work better. Your health depends on both.

Study Details

Study typeRct
EvidenceLevel 2
PublishedMar 2026
View Original Abstract ↓
IntroductionSkeletal fluorosis patients face a markedly elevated risk of cardiovascular metabolic abnormalities, including endothelial dysfunction, excessive oxidative stress, and impaired calcium-phosphate metabolism. Current clinical interventions for this condition are limited to symptomatic analgesia and conventional anti-osteoporotic treatments, and lack targeted therapeutic strategies for the “kidney deficiency and blood stasis” pathogenesis of skeletal fluorosis that can synergistically protect both the skeletal and cardiovascular systems.MethodsThis multicenter randomized controlled trial was conducted on 1,480 skeletal fluorosis patients from the China Fluorosis Cohort (CFC), to investigate the synergistic therapeutic effects of three traditional Chinese medicine (TCM) combinations—Ginkgo biloba combined with Epimedium (Drug 1), Xianling Gubao combined with Eucommia ulmoides (Drug 2), and Gusongbao combined with Rosa roxburghii (Drug 3)—in conjunction with lifestyle modifications on cardiovascular metabolic outcomes.ResultsSmoking and alcohol consumption were identified as independent risk factors for reduced therapeutic efficacy in skeletal fluorosis patients with comorbid cardiovascular metabolic abnormalities (OR = 2.755, 95% CI: 1.400 –5.421). Among the three TCM combinations, Drug 2 and Drug 3 significantly counteracted these adverse risk factors, reducing the risk of treatment failure by 53.9% (OR = 0.461) and 57.0% (OR = 0.430), respectively. Drug 3 exhibited superior efficacy in reducing diastolic blood pressure (β = −2.263, P = 0.010), while its systolic blood pressure-lowering effect diminished with increasing age. Drug 2 showed synergistic benefits with improved sleep quality (β = 1.596, P = 0.002) and healthy dietary habits (β = −1.180, P = 0.001), which enhanced its antihypertensive effects and led to a significant reduction in low-density lipoprotein cholesterol (LDL-C) levels (P < 0.05). Additionally, the interaction models outperformed the main-effect models, confirming the dynamic synergistic effect between lifestyle interventions and TCM pharmacotherapy.DiscussionThese findings highlight the clinical necessity of integrating behavioral interventions with pharmacotherapy to optimize cardiovascular metabolic safety in the clinical management of skeletal fluorosis. Based on these results, we propose a novel theoretical framework—Personalized Behavioral-Integrated Therapy (PBIT)—which guides the incorporation of patient-specific behavioral and demographic factors into tailored treatment strategies, thereby improving the precision and clinical outcomes of skeletal fluorosis treatment.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.